These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 29256045

  • 21. Hexokinase and glucose-6-phosphatase activity in woodchuck model of hepatitis virus-induced hepatocellular carcinoma.
    Kuang Y, Schomisch SJ, Chandramouli V, Lee Z.
    Comp Biochem Physiol C Toxicol Pharmacol; 2006 Jun; 143(2):225-31. PubMed ID: 16581304
    [Abstract] [Full Text] [Related]

  • 22. The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions.
    Cheong SJ, Lee CM, Kim EM, Lim ST, Sohn MH, Jeong HJ.
    Nucl Med Biol; 2015 Feb; 42(2):85-91. PubMed ID: 25441255
    [Abstract] [Full Text] [Related]

  • 23. Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling.
    Cooper AC, Fleming IN, Phyu SM, Smith TA.
    J Cancer Res Clin Oncol; 2015 Sep; 141(9):1523-32. PubMed ID: 25579456
    [Abstract] [Full Text] [Related]

  • 24. PET Imaging of Hepatocellular Carcinomas: 18F-Fluoropropionic Acid as a Complementary Radiotracer for 18F-Fluorodeoxyglucose.
    Zhao J, Zhang Z, Nie D, Ma H, Yuan G, Su S, Liu S, Liu S, Tang G.
    Mol Imaging; 2019 Sep; 18():1536012118821032. PubMed ID: 30799682
    [Abstract] [Full Text] [Related]

  • 25. Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma.
    Lee M, Ko H, Yun M.
    Yonsei Med J; 2018 Dec; 59(10):1143-1149. PubMed ID: 30450847
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines.
    Ahn KJ, Hwang HS, Park JH, Bang SH, Kang WJ, Yun M, Lee JD.
    J Nucl Med; 2009 Sep; 50(9):1525-32. PubMed ID: 19690031
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.
    Wang H, Zhang J, Tian J, Qu B, Li T, Chen Y, Liu J, Wang S.
    J Nucl Med; 2009 Nov; 50(11):1857-64. PubMed ID: 19837754
    [Abstract] [Full Text] [Related]

  • 36. Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.
    Zhou X, Chen J, Yi G, Deng M, Liu H, Liang M, Shi B, Fu X, Chen Y, Chen L, He Z, Wang J, Liu J.
    Oncotarget; 2016 Jan 05; 7(1):873-84. PubMed ID: 26621849
    [Abstract] [Full Text] [Related]

  • 37. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
    Kim YK, Lee KW, Cho SY, Han SS, Kim SH, Kim SK, Park SJ.
    Liver Transpl; 2010 Jun 05; 16(6):767-72. PubMed ID: 20517911
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.